Olema Pharmaceuticals, Inc. · Brief

Next report

9 days

Nov 9 · before openest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 8≥ implied

Mar 18 '25±13.0%▼−0.72%×0.06

May 13 '25±78.5%▼−3.85%×0.05

Aug 11 '25±13.6%▲+16.19%×1.19

Q3 FY25±12.1%▲+4.19%×0.35

Jan 12 '26±6.4%▼−3.13%×0.49

Q1 FY26±31.6%▲+12.85%×0.41

May 12 '26±32.7%▼−5.99%×0.18

Q2 FY26±30.4%▼−12.65%×0.42

quarterimplied−80%0+80%realized×

Q2 FY26±30.4%▼−12.65%×0.42

May '26±32.7%▼−5.99%×0.18

Q1 FY26±31.6%▲+12.85%×0.41

Jan '26±6.4%▼−3.13%×0.49

Q3 FY25±12.1%▲+4.19%×0.35

Aug '25±13.6%▲+16.19%×1.19

2 older reports

May '25±78.5%▼−3.85%×0.05

Mar '25±13.0%▼−0.72%×0.06

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 9 report · est.

Bull2

184managers reporting a position in the latest quarterly filings13F · Jun 30 '26

4tracked funds holding OLMAN-PORT · Aug 31 '26

Bear2 of 3

4 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

7 of 8recent reports where the move came in under the options-implied rangeEarnings history

AI captions · Sep 28 '26once per report · top 2 per case

OLMA report session

No linked exposure.

Oct 27impliedImplied move: ±35.6% into Nov 9 earnings (Oct 27 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.